Search results
More workers finding reasons to stay in their jobs, a shift from the Great Resignation
Yahoo Finance· 2 hours agoIt seems to be working. Workers report they’re satisfied with their pay (48%), job security (41%),...
Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?
Motley Fool via Yahoo Finance· 22 hours agoWhen adding in its dividends, however, the picture for Kraft Heinz becomes brighter. Since 2019, the...
Autism, dyslexia, ADHD. How the University of San Diego is helping 'neurodivergent' students succeed
Los Angeles Times· 2 hours agoNiki Elliot skipped the fifth grade. “Embodied equity,” the other term in the new center’s name,...
How Women of Color Can Prioritize Their Mental Health
Teen Vogue via Yahoo News· 6 days agoRemember...your voice to challenge misconceptions and advocate for policies and programs that...
Recalling the 2012 Wisconsin governor recall
The Washington Times· 7 days agoJune 5 is the anniversary of our recall election victory. Since 2011, our reforms have saved the hardworking taxpayers of Wisconsin more than $31...
Charles Schwab Increases Its Stake in Chewy Stock. Should You Do the Same?
Motley Fool via Yahoo Finance· 6 days agoThe company sells just about everything you may need for your furry and not-so-furry friends -- from...
Schedule set for Jazz in the City, a series of concerts with a public-health focus – Central New...
Central New York Business Journal· 6 days agoSYRACUSE, N.Y. — The 20th season of Jazz in the City, a series of summer concerts with a focus on...
Opinion | Why the New Human Case of Bird Flu Is So Alarming
New York Times· 4 days agoDr. Bright is a virologist and the former head of the Biomedical Advanced Research and Development...
Is It Too Late to Buy Chewy Stock?
Motley Fool via Yahoo Finance· 6 days agoBrighter days could finally be ahead In the first quarter, Chewy's active customers declined 2% year over year to just under...active customer improved...
Why Counterfeit Ozempic Is a Global-Growth Industry
Vanity Fair· 2 days agoMeanwhile, the cost of the GLP-1 drugs—roughly $12,000 a year without insurance—places them beyond the reach of most patients who need them. Apovian’s...
